ContractOption, License and Development Agreement • March 15th, 2013 • Lpath, Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 15th, 2013 Company IndustryCERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
OPTION, LICENSE AND DEVELOPMENT AGREEMENT by and between PFIZER INC. and LPATH, INC.Option, License and Development Agreement • March 23rd, 2011 • Lpath, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 23rd, 2011 Company Industry Jurisdiction*** Certain confidential portions of this Exhibit were omitted by means of blackout of the text (the “Mark”). This Exhibit has been filed separately with the Secretary of the Commission without the Mark pursuant to the Company’s Application Requesting Confidential Treatment under Rule 24b-2 under the 1934 Act.